Thousands allege serious harm from GLP-1 weight loss drugs like Ozempic and Wegovy, with lawsuits targeting Novo Nordisk and ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

The disruptive force of weight loss drugs: How GLP-1s do more than shed pounds - The impacts of weight-loss medications reach ...

Glucagon-like peptide agonists, or GLP-1, are seen by many as miracle drugs based on dramatic weight loss.

Add Yahoo as a preferred source to see more of our stories on Google. Wegovy pens are sorted at a packaging line at Novo Nordisk's facility in Hillerod, Denmark, March 8, 2024. REUTERS/Tom Little Dec ...

“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Eli Lilly's GLP-1 weight loss drug is leading investors to award it a massive P/E ratio of 53. That's far higher than the pharmaceutical sector's average P/E ratio of about 30. Merck, Bristol Myers ...